Table 3 Health conditions, types of surveillance, and types of health products investigated
From: Utility of social media and crowd-intelligence data for pharmacovigilance: a scoping review
Topic (n = 70) | Count (%) | |
|---|---|---|
Health conditions studied as per ICD-10 | Multiple disease system | 32 (45.7%) |
Neoplasm | 9 (12.9%) | |
Mental illness & behavioural disorders | 8 (11.4%) | |
Factors influencing health status & contact with health services | 6 (8.6%) | |
Nervous system | 6 (8.6%) | |
Endocrine, nutritional & metabolic | 3 (4.3%) | |
Not reported | 2 (2.9%) | |
Circulatory system | 2 (2.9%) | |
Injury, poisoning and certain other consequences of external causes | 1 (1.4%) | |
Skin & subcutaneous tissue | 1 (1.4%) | |
Type of surveillance studied | Any adverse event | 52 (74.3%) |
Drug abuse/misuse | 6 (8.6%) | |
Drug-to-drug interaction | 4 (5.7%) | |
Specific adverse event (e.g., arthralgia, heart diseases, infertility) | 7 (10.0%) | |
Treatment switching | 1 (1.4%) | |
Type of health products included | Pharmaceutical drugs (including biologics) | 69 (98.6%) |
Medical devices | 1 (1.4%) | |
Natural health products | 0 (0.0%) | |